Back to NBIX
DODGE & COX NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
13
Latest value
$941.2M
Q2 2026
Peak value
$941.2M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $24M |
| Q4 2023 | $166M |
| Q4 2023 | $166M |
| Q1 2024 | $174.5M |
| Q2 2024 | $176.3M |
| Q3 2024 | $148.4M |
| Q4 2024 | $411.7M |
| Q1 2025 | $612.1M |
| Q2 2025 | $699.7M |
| Q3 2025 | $780M |
| Q4 2025 | $781.2M |
| Q1 2026 | $719.4M |
| Q2 2026 | $941.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $941.2M | 5.58M | — | — |
| Q1 2026 | $719.4M | 5.46M | — | — |
| Q4 2025 | $781.2M | 5.51M | — | — |
| Q3 2025 | $780M | 5.56M | — | — |
| Q2 2025 | $699.7M | 5.57M | — | — |
| Q1 2025 | $612.1M | 5.53M | — | — |
| Q4 2024 | $411.7M | 3.02M | — | — |
| Q3 2024 | $148.4M | 1.29M | — | — |
| Q2 2024 | $176.3M | 1.28M | — | — |
| Q1 2024 | $174.5M | 1.27M | — | — |
| Q4 2023 | $166M | 1.26M | — | — |
| Q4 2023 | $166M | 1.26M | — | — |
| Q3 2023 | $24M | 213.6K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$917.9M
$900M
Other DODGE & COX positions
JCI
$8.1BJohnson Controls International PLC
SCHW-PJ
$7.9BThe Charles Schwab Corp.
SCHW-PJ
$7.7BThe Charles Schwab Corp.
SCHW-PJ
$7.6BThe Charles Schwab Corp.
JCI
$7.5BJohnson Controls International PLC
JCI
$7.2BJohnson Controls International PLC
SCHW-PJ
$7.1BThe Charles Schwab Corp.
JCI
$7.1BJohnson Controls International PLC